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a b s t r a c t
Chocolate and cocoa ﬂavanols have been associated with improvements in a range of health complaints
dating from ancient times, and has established cardiovascular beneﬁts. Less is known about the effects of
chocolate on neurocognition and behaviour. The aim of this study was to investigate whether chocolate
intake was associated with cognitive function, with adjustment for cardiovascular, lifestyle and dietary
factors. Cross-sectional analyses were undertaken on 968 community-dwelling participants, aged 23e98
years, from the Maine-Syracuse Longitudinal Study (MSLS). Habitual chocolate intake was related to
cognitive performance, measured with an extensive battery of neuropsychological tests. More frequent
chocolate consumption was signiﬁcantly associated with better performance on the Global Composite
score, Visual-Spatial Memory and Organization, Working Memory, Scanning and Tracking, Abstract
Reasoning, and the Mini-Mental State Examination. With the exception of Working Memory, these re-
lations were not attenuated with statistical control for cardiovascular, lifestyle and dietary factors.
Prospective analyses revealed no association between cognitive function and chocolate intake measured
up to 18 years later. Further intervention trials and longitudinal studies are needed to explore relations
between chocolate, cocoa ﬂavanols and cognition, and the underlying causal mechanisms.
© 2016 Elsevier Ltd. All rights reserved.
1. Introduction
Chocolate consumption is widespread throughout the world. In
2009, 7.2 million tons of chocolate was consumed worldwide
(Statista, 2015). Commonly associated with pleasure and enjoy-
ment, chocolate is a frequently ‘craved’ food (Macht & Dettmer,
2006; Macht & Mueller, 2007; Parker, Parker, & Brotchie, 2006),
possibly due to its rich natural complexity (Wilson, 2010). The
sweet taste, high carbohydrate and fat content and highly palatable
orosensory qualities, obtained from its speciﬁc constituents, may all
contribute to its appeal as a ‘comfort’ food. Few other natural
products have been purported to have as many medicinal beneﬁts
as chocolate. From very early times to the present day, chocolate
has been used to reduce fever, treat childhood diarrhoea, promote
strength before sexual conquests, decrease ‘female complaints’,
increase breast-milk production, encourage sleep and to clean
teeth (Wilson, 2010). More recent scientiﬁc interest has been
directed at the cardiovascular (Heiss, Keen, & Kelm, 2010; Hooper
et al., 2012) and neurocognitive beneﬁts (Scholey & Owen, 2013;
Sokolov, Pavlova, Klosterhalfen, & Enck, 2013) derived from choc-
olate and cocoa consumption. The cardiovascular beneﬁts have
been well established from dietary intervention trials showing
improvements in insulin sensitivity (Grassi, Lippi, Necozione,
Desideri, & Ferri, 2005), blood pressure (Grassi et al., 2005),
endothelial function (Engler et al., 2004; Heiss et al., 2007) and
cerebral blood ﬂow (Sorond, Lipsitz, Hollenberg, & Fisher, 2008). In
contrast to the evidenced-based beneﬁts from cocoa and chocolate
consumption on cardiovascular health, the precise impact of
chocolate on human cognitive function is less clear.
Ageing is usually accompanied by declines in multiple domains
of cognitive function, including memory and processing speed. In
the absence of effective treatments for neurodegenerative disor-
ders, nutritional practises targeted at preventing or slowing
cognitive decline may contribute signiﬁcantly towards optimising
cognitive functioning across the adult life-span (Bryan, 2004;
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Solfrizzi, Panza, & Capurso, 2003; Van Dyk & Sano, 2007; Crichton,
Bryan, Murphy, & Buckley, 2010; Crichton et al., 2012; Haider et al.,
2011). The ability of ﬂavonoid-rich foods to improve cognitive
function has been demonstrated in both epidemiological studies
(Letenneur, Proust-Lima, Le Gouge, Dartigues, & Barberger-Gateau,
2007; Nurk et al., 2009) and clinical trials (Macready et al., 2009).
Chocolate and cocoa products are a rich source of ﬂavonoids.
Flavanoids, naturally occurring polyphenolic compounds present in
plant-based foods, represent up to 20% of the compounds present
in cocoa beans (Sokolov et al., 2013). Flavanols, and in particular
epicatechin, are a subgroup of ﬂavonoids, and are the most com-
mon cocoa ﬂavonoids (Sokolov et al., 2013). High levels of ﬂavanols
are also found in tea, red wine, and fruits such as grapes and apples
(Gu et al., 2004). In addition to cocoa ﬂavonols, other psychoactive
components of chocolate include themethylxanthines, caffeine and
theobromine, both of which have been associated with improving
alertness and cognitive function (Smit, Gaffan, & Rogers, 2004;
Mitchell et al., 2011). The amount of cocoa in chocolate ranges
from approximately 7e15% in milk chocolate, to 30e70% in dark
chocolate. One hundred grams of dark chocolate contains approx-
imately 100 mg of ﬂavanols, while 100 g of unsweetened cocoa
powder without meythlxanthines can contain up to 250 mg of
ﬂavanols (Bhagwat, Haytowitz, Holden).
Two randomized trials have demonstrated improvements in
cognitive function following a single dose of chocolate or cocoa
ﬂavanols (Scholey et al., 2010; Field, Williams, & Butler, 2011).
Beneﬁts to information processing speed and working memory
were observed in these studies within hours of consuming cocoa
ﬂavanols or dark chocolate. Less research has examined the effects
from the longer-term consumption of chocolate or cocoa. One
recent randomized controlled trial, the Cocoa, Cognition, and Aging
(CoCoA) Study, has provided evidence that daily consumption of
cocoa ﬂavanols can improve cognitive function in healthy, elderly
individuals (Mastroiacovo et al., 2015). Consistent with the imme-
diate effect studies (Field et al., 2011; Scholey et al., 2010), im-
provements in processing speed and attentional tasks were seen
following 8-weeks of consuming an intermediate to high daily dose
of cocoa ﬂavanols (Mastroiacovo et al., 2015).
In contrast to the aforementioned research, some studies using a
more chronic administration of chocolate or cocoa ﬂavanols,
ranging from 5 days to 6 weeks, have failed to ﬁnd any positive
effects on cognition (Crews, Harrison, & Wright, 2008; Camﬁeld
et al., 2012; Francis, Head, Morris, & Macdonald, 2006). It is
possible that the variability in the ﬂavanol content in chocolate,
which may vary according to the bean variety, origin and
manufacturing processes, may contribute to the mixed outcomes
observed in studies to date on the effects of cocoa ﬂavanols on
cognition (Sokolov et al., 2013).
We have not identiﬁed any cohort studies that have examined
associations between longer-term habitual chocolate consumption
over a number of years, with cognitive functioning measures. The
existing evidence remains limited and inconclusive. Using data
collected from participants in the Maine-Syracuse Longitudinal
Study (MSLS), the aim of the present study was to determine
whether habitual chocolate intake is associated with improved
cognitive function, with consideration given to cardiovascular,
lifestyle and dietary factors.
2. Materials and methods
2.1. Participants
The MSLS was a community-based study of cardiovascular risk
factors and cognitive functioning in adults (Dore, Elias, Robbins,
Budge, & Elias, 2008; Elias, Robbins et al., 2009; Elias et al., 2006;
Robbins, Elias, Elias, & Budge, 2005). The MSLS consists of ﬁve co-
horts deﬁned by time of entry into the study (1975e2000, see
Appendix 1). At initial recruitment, participants were living inde-
pendently in Syracuse, New York State. Participants in the present
study were those returning for the sixth study wave (2001e2006),
as dietary intake measures and extensive data on risk factors for
CVD were ﬁrst obtained at wave 6. From a sample of 1049 in-
dividuals, participants were excluded for the following reasons:
missing dietary or cognitive data (n ¼ 38), acute stroke (n ¼ 28),
probable dementia (n ¼ 8), undertaking dialysis treatment (n ¼ 5),
inability to read English (n ¼ 1), and prior alcohol abuse (n ¼ 1),
leaving 968 participants. Dementia cases were excluded as wewere
interested in examining relationships between diet and cognitive
performance in those without severe cognitive impairment
because poorer cognitive performance in such individuals is a
major risk factor for dementia (Elias et al., 2000; Tierney,
Moineddin, & McDowell, 2010) and Alzheimer's Disease (Tierney,
Yao, Kiss, & McDowell, 2005). The clinical diagnosis of dementia
was determined by committee using the National Institute of
Neurological and Communicative Diseases and Stroke/Alzheimer's
Disease and Related Disorders Association (NINCDS-ADRDA)
criteria, MSLS cognition data, diagnostic records and medical
interview data (McKhann et al., 1984). Stroke was deﬁned as a focal
neurological deﬁcit of acute onset persisting for more than 24 h,
and was based on self-report or medical records.
This study was conducted according to the guidelines laid down
in the Declaration of Helsinki and all procedures were approved by
the University of Maine Institutional Review Board. Written
informed consent was obtained from all subjects.
2.2. Procedure and assessment
Dietary Intake Dietary intake was also assessed using the
Nutrition and Health Questionnaire (Kaaks & Riboli, 1997; Riboli &
Kaaks, 1997). Participants were required to stipulate how
frequently they consume a list of foods, including meat, ﬁsh, eggs,
breads, cereals, rice and pasta, fruit, vegetables, dairy foods, choc-
olate, nuts, other snack-type foods and beverages, including tea,
coffee, water, fruit juice and alcohol. Participants were required to
stipulate how frequently they consumed each food, from six
response options: never, seldom, once/week, 2e4 times/week, 5e6
times/week, and once or more per day. Chocolate was not differ-
entiated according to type, ie. milk, dark or white chocolate.
In order to estimate mean intake of the major food groups and
total energy intake, the median score within each response option
was used to estimate total intake per week; for example, 2e3 times
per week was estimated at 2.5. The mean number of times each
foodwas consumed on aweekly and then daily basis was calculated
for all foods in the questionnaire. Because portion sizes were not
stipulated to participants, these totals are an estimate of the
number of times each food was consumed on a daily basis. Indi-
vidual foods were categorised into ﬁve major food groups e grains,
fruits, vegetables, protein foods, and dairy foods e based on the
USDA Food Guide Pyramid (United States Department of
Agriculture, 2011). Intake of individual foods and beverages
within each food group were summed to give an estimate of total
intake for each group. An estimation of total energy intake was
calculated by adding intake of all food groups, and was used to
control for energy intake in subsequent analyses.
Cognitive Function Cognitive function was assessed using the
MSLS neuropsychological test battery, which has been used in
numerous health and cognition studies (Dore et al., 2008; Elias,
Robbibs et al., 2009, 2006; Robbins et al., 2005; Elias, Elias et al.,
2009). The following composite scores have been previously
derived using factor analysis from 20 individual tests designed to
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measure a wide range of cognitive domains: visual-spatial memory
and organization, scanning and tracking, verbal episodic memory,
and working memory. TheWAIS Similarities Test (Lezak, Howieson,
& Loring, 2004), a measure of abstract reasoning, loaded on all
composite scores (factors) and was thus employed separately. A
global cognition composite score was derived by averaging the z-
scores for all individual tests and then re-standardizing these
scores to obtain a z-score with a mean of zero and SD of 1.00. In
addition, the Mini-Mental State Examination (MMSE) (Folstein,
Folstein, & McHugh, 1975), a global measure of mental status
widely used in the literature, was included in the MSLS battery. The
derivation of these composites has been described previously (Elias
et al., 2006) and they have been repeatedly utilized inMSLS studies.
All cognitive performance measures are expressed in the same unit
of measurement (SD units), i.e. z-scores, with higher scores indi-
cating better performance.
Demographics and Physical Health Assessment Demographic,
socioeconomic and lifestyle characteristics were obtained from the
Nutrition and Health Questionnaire (Kaaks & Riboli, 1997; Riboli &
Kaaks, 1997). Data obtained included smoking history, marital
status and medical history. Physical activity was measured with the
Nurses' Health Study Activity Questionnaire, a validatedmeasure of
time spent engaging in various physical activities (Wolf et al., 1994).
The Center for Epidemiological Studies Depression Scale (CES-D)
(Radloff, 1977) was used to assess depressive symptoms. Education
level was obtained through self-report (mean ¼ 14.7 ± 2.7 years,
range 4e20 years).
Standard assay methods were employed (Elias et al., 2006) to
obtain fasting plasma glucose (mg/dL), total cholesterol (TC, mg/
dL), low-density lipoprotein cholesterol (LDL, mg/dL), high-density
lipoprotein cholesterol (HDL, mg/dL), triglycerides (mg/dL) and C-
reactive protein (CRP, mg/L), following an overnight fast. Body
weight was measured with participants wearing light clothing to
the nearest 0.1 kg, and height was measured with a vertical ruler to
the nearest 0.1 cm. Body mass index (BMI) was calculated as weight
in kilograms divided by height in metres squared. Waist circum-
ference (in centimetres) was taken over light clothing, using a non-
extendablemeasuring tape, at the level of the iliac crest. Automated
blood pressure measures (GE DINAMAP 100DPC-120XEN, GE
Healthcare) were taken in the right arm ﬁve times each in
recumbent, standing and sitting position after a supine rest for
15 min, and averaged for systolic and diastolic blood pressure.
Obesity was deﬁned as having BMI of at least 30 kg/m2.
3. Statistical analyses
Participant demographics, health and dietary variables, and
cognitive scores were compared according to chocolate consump-
tion (never/rarely vs. at least once/week). Independent samples t-
tests were used for continuous variables and Chi-square for cate-
gorical variables.
For the primary analyse, chocolate intake was further classiﬁed
into three intake groups based on self-reported frequency of con-
sumption: less than once per week, once per week, and more than
once per week. Multivariate analysis of variance (MANOVA) (a step-
down protection procedure) (van der Laan, Dudoit,& Pollard, 2004)
was used to examine relationships between chocolate intake and
cognitive performance (Visual-Spatial Memory and Organization,
Scanning and Tracking, Verbal Episodic Memory, Working Memory,
Similarities, MMSE). All cognitive outcomes were entered into the
analyses simultaneously as dependent variables except for the
Global Composite score, as the Global Composite is co-dependent
on all the measures other than the MMSE. Multivariate ANOVA
was used to examine relationships between chocolate intake and
the Global Composite. In addition to MANOVA, the Bonferroni
procedure was used to protect against multiple comparisons.
Potential confounding factors were identiﬁed on the basis of
two criteria: (1) had to be theoretically relevant (Jaccard & Jacoby,
2010) and, (2) had to show a statistically signiﬁcant association
(p < 0.05) with both chocolate intake and the Global Composite.
Three covariate sets were used:
(1) Covariate set 1: age, sex.
(2) Covariate set 2: age, sex, education, total cholesterol, glucose,
LDL-cholesterol, hypertension, estimated energy intake (to-
tal daily intake of all food groups as previously described).
(3) Covariate set 3: covariate sets 1 and 2, plus dietary intake of
alcohol, meats, vegetables, and dairy foods.
The other risk factors measured as potential covariates did not
correlate signiﬁcantly with chocolate consumption (predictor) or
an outcome measure and therefore were not included in the sta-
tistical models.
All statistical analyses were performed with PASW for Win-
dows® version 21.0 software (formerly SPSS Statistics Inc. Chicago,
IL, USA); p < 0.05 was considered statistically signiﬁcant.
4. Results
4.1. Participant characteristics and chocolate consumption
Table 1 shows the demographic and health-related variables,
cognitive scores, and dietary intake for MSLS participants (n¼ 968),
according to chocolate consumption (those who consume choco-
late never or rarely, compared with at least once per week). Effect
sizes are shown for those variables where there were signiﬁcant
differences between groups (p < 0.05). Women ate chocolate more
frequently than men. Compared to those who never or rarely ate
chocolate, those who ate chocolate on a weekly basis, had higher
total and LDL-cholesterol, but lower glucose levels. Hypertension
and type 2 diabetes were lower in regular chocolate consumers
than in non-consumers. From a dietary perspective, those who ate
chocolate also consumed more energy overall, and more daily
serves of meat, vegetables and dairy foods, but signiﬁcantly less
alcohol. All cognitive scores were signiﬁcantly higher in those who
consumed chocolate at least once per week, than in those who
never/rarely consumed chocolate.
4.2. Chocolate Consumption and Cognitive Performance in the
MSLS.
The multivariate tests performed as protection against multiple
contrasts for multiple outcome variables were statistically signiﬁ-
cant for all three models (covariate set 1: F [Wilks' lambda] ¼ 2.93,
p < 0.001; covariate set 2: F ¼ 2.43, p ¼ 0.004; covariate set 3:
F ¼ 2.21, p ¼ 0.009). Therefore we report the results of the uni-
variate analyses for each cognitive outcome.
Table 2 shows the adjusted mean z-scores (and SE) for each
cognitive outcome across increasing categories of chocolate
intake (all three models). P-values are adjusted via the Bonferroni
procedure. Chocolate intake was signiﬁcantly and positively
associated with the Global Composite, Visual-Spatial Memory
and Organization, Working Memory, Scanning and Tracking, the
Similarities test (abstract reasoning), and the MMSE (covariate
set 1, all p < 0.05).
With full adjustment for demographic variables, cardiovascular
risk factors, and a number of dietary variables including total en-
ergy intake, signiﬁcant positive associations remained between
chocolate intake and the Global Composite, Visual-Spatial Memory
and Organization, Scanning and Tracking, Similarities and the
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MMSE (covariate set 3, all p < 0.05). There were no associations
observed between chocolate intake and Verbal Memory.
5. Secondary analyses
In a secondary analysis, we asked whether cognitive perfor-
mance predicted chocolate consumption rather than the other way
round. This analysis was conducted on a sample of participants
(n ¼ 333) who had completed a cognitive assessment in waves 1e4
of the MSLS, but also completed the dietary questionnaire at wave
6, a mean of 18.0 years later (Crichton, Elias, Davey, Alkerwi,&Dore,
2014). Cognition was assessed using the Wechsler Adult Intelli-
gence Scale (WAIS) (Wechsler, 1955), consisting of a total WAIS
score, Verbal subscale score and Performance subscale score. There
were no signiﬁcant associations between chocolate intake and the
total WAIS (p ¼ 0.90), Verbal subscale (p ¼ 0.70) or Performance
subscale (p ¼ 0.80) (all adjusted for age, sex and education).
Although income did not ﬁt our criteria for inclusion as a co-
variate (did not correlate signiﬁcantly with chocolate intake), it
may inﬂuence food choices and dietary patterns. We therefore
added income to the basic model, and the results remain
unchanged.
6. Discussion
Chocolate intake was positively associated with cognitive per-
formance, across a range of cognitive domains in this dementia-
free, community-dwelling population. The associations between
more frequent weekly chocolate consumption and cognitive per-
formance remained signiﬁcant after adjustment for a number of
cardiovascular risk factors, including total and LDL-cholesterol,
glucose levels, and hypertension. Associations were not attenu-
ated with the addition of dietary variables (alcohol, meats, vege-
tables, and dairy foods), indicating that chocolate may be
associated with cognition irrespective of other dietary habits.
A number of studies provide support for the role of cocoa ﬂa-
vanols in cognition (Field et al., 2011; Mastroiacovo et al., 2015;
Scholey et al., 2010). In a placebo-controlled, double blind study,
(Scholey et al. 2010) compared cognitive effects following the
consumption of drinks containing either 520 mg of cocoa ﬂavanols,
Table 1
Participant characteristics according to baseline chocolate consumption in MSLS, N ¼ 968.
Characteristic Chocolate consumption Cohen's de
Never or rarely n¼ 337 (34.8%) At least once/week n ¼ 631
(65.2%)
Mean SD Mean SD




Education (years) 14.5 2.8 14.7 2.7
CES-D 7.6 7.2 7.6 6.6
C-reactive protein (mg/L) 0.4 0.5 0.4 0.5
Smoking (cigarettes/day) 1.5 5.4 1.3 5.2
Body mass index (kg/m2) 29.6 6.6 29.2 5.5
Waist circumference (cm) 96.3 16.5 94.9 14.2
Physical activity (MET hours) 19.3 25.9 21.3 28.4
Systolic blood pressure (mm Hg) 132 22 130 21
Diastolic blood pressure (mm Hg) 70.7 10.7 70.3 9.7
Total cholesterol (mg/dL) 197 40 204* 40 0.16
HDL cholesterol (mg/dL) 53.9 16.1 53.3 14.9
LDL cholesterol (mg/dL) 116 34 123** 33 0.21
Triglycerides (mg/dL) 145 128 142 103
Glucose (mg/dL) 103 37 97** 21 0.27
Obesitya, % 39.5 38.4
Hypertensionb, % 67.7 58.3**
Diabetesc, % 17.5 9.8**
Dietary (serves per day)
Total all food groups 13.8 4.7 15.4*** 4.4 0.36
Total grains 3.6 2.8 3.8 1.9
Total meats 1.9 0.8 2.1** 0.9 0.24
Total fruit 1.5 0.9 1.7 1.0
Total vegetables 2.6 1.1 2.8** 1.1 0.24
Total dairy foods 1.8 1.1 2.1** 1.1 0.21
Alcohol (g/week) 48.2 95.1 29.5*** 50.2 0.37
Cognitive outcomesd
Global Composite 0.15 0.06 0.09*** 0.04 0.24
Visual Spatial Memory and Organization 0.16 0.06 0.10*** 0.04 0.25
Verbal Memory 0.11 0.05 0.06* 0.04 0.17
Working Memory 0.08 0.05 0.05 0.04 0.13
Scanning and Tracking 0.11 0.06 0.06* 0.04 0.17
Similarities 0.14 0.06 0.08** 0.04 0.22
Mini-Mental State Examination 0.08 0.06 0.05* 0.04 0.14
CES-D Center for Epidemiological Studies Depression Scale, HDL high-density lipoprotein, LDL low-density lipoprotein.
*p < 0.05, **p < 0.01, ***p < 0.001 for differences between groups.
a Obesity deﬁned as body mass index 30 kg/m2.
b Hypertension deﬁned as systolic blood pressure 140 mmHg and/or diastolic blood pressure 90 mmHg, and/or taking antihypertensive medications.
c Diabetes deﬁned as fasting plasma glucose 126 mg/dL, or taking antidiabetic medications.
d Mean z-scores and SE.
e Effect sizes reported where p < 0.05.
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994 mg of cocoa ﬂavanols, or a matched control drink in 30 healthy
young adults. Mood and cognitive performance were assessed over
60 min post-drink. Performance on a serial subtraction task
signiﬁcantly improved following consumption of both ﬂavanol-
containing drinks, compared to the control. The 994 mg cocoa
ﬂavanol beverage signiﬁcantly increased the speed on visual in-
formation processing responses, while increases in self-reported
‘mental fatigue’ were signiﬁcantly attenuated by the consumption
of the 520 mg beverage.
(Field et al. 2011) similarly examined the acute effects of cocoa
ﬂavanols on cognitive function (reaction time, visual spatial
working memory), visual contrast sensitivity, and motion sensi-
tivity, in a cross-over study in 30 healthy young adults. Participants
consumed dark chocolate containing 720 mg cocoa ﬂavanols, and a
matched quantity of white chocolate. The dark chocolate improved
visual spatial working memory, reaction time on some aspects of
the test, contrast sensitivity, and reduced the time to detect motion
direction. The authors attributed these ﬁndings to increased cere-
bral blood ﬂow caused by the cocoa ﬂavanols. Findings from these
two studies demonstrated that improved cognitive effects may be
observed at 90e120 min post-ﬂavanol intake (Field et al., 2011;
Scholey et al., 2010).
Findings from the recent CoCoA Study support this research
(Mastroiacovo et al., 2015). In this trial, the effects of daily con-
sumption (for 8 weeks) of a drink containing low (48 mg), inter-
mediate (520 mg), or high (993 mg) levels of cocoa ﬂavanols on
cognitive performance in 90 elderly, cognitively intact participants
were examined. The intermediate and high ﬂavanol groups both
showed improvements in processing speed and attentional tasks
(measured by the Trail Making Test), whilst improvements in verbal
ﬂuency (Verbal Fluency Test) were greatest for the high ﬂavanol
group. General cognition scores, as measured by the MMSE, were
not signiﬁcantly different between groups post-treatment. Further,
improvements in insulin resistance, blood pressure, and lipid pro-
ﬁle were detected in the high and intermediate ﬂavanol groups,
compared with the low ﬂavanol group. Importantly, beneﬁts were
noted at multiple intake amounts. Some improvement was
observed in the low ﬂavanol group for verbal ﬂuency, however to a
lesser degree than in the other two treatment groups. The authors
attributed this to the meythlxanthines (50 mg caffeine, 400 mg
theobromine) in the low ﬂavanol drink (Mastroiacovo et al., 2015).
Other research has supported the action of the methylxanthines
in chocolate, caffeine and theobromine, in relation to cognitive
function. Coffee is consumed bymillions of individuals from all over
the world, possibly in part, due to its caffeine content. It is the best
known psychoactive stimulant acting to improve short-term
alertness and arousal (Mitchell et al., 2011; Yoshimura, 2005).
Longer-term, population based studies have provided evidence that
long-term caffeine intake may offer some protection against
cognitive decline (Panza et al., 2015).
Studies by (Smit et al. 2004) have provided evidence for the
beneﬁcial effects of the methylxanthines contained in chocolate.
They measured the effects on cognitive performance and mood
from the consumption of the equivalent amount of cocoa powder
and methylxanthines (caffeine and theobromine combination)
found in a 50 g bar of dark chocolate. Identical improvements on
energetic arousal and cognitive function were found for cocoa
powder and the methylxanthines versus a placebo. In chocolate,
both ‘milk’ and ‘dark’ chocolate methylxanthine doses improved
cognitive function compared with ‘white chocolate’. In subsequent
work, Smit and Blackburn (2005) also demonstrated that the
methylxanthines in amounts found in 50 g of chocolate may well
contribute to our ‘liking’ of chocolate.
Other studies have supported the ﬁndings of (Smit et al. 2004).
(Mitchell et al. 2011) compared the effects of caffeine (120 mg),
theobromine (700 mg), the combination of both, or a placebo, on
mood and cognitive performance (psychomotor speed). Theobro-
mine alone decreased calmness, caffeine alone increased alertness
and contentedness, while the combination of both had similar ef-
fects as caffeine alone on mood, although neither improved
Table 2
Multivariate adjusted mean (z-scores) (and SE) for each cognitive outcome across increment levels of chocolate intake, N ¼ 968.
Cognitive outcome Covariate seta Chocolate intake category R2b p linear
<once/week
n ¼ 337 (34.8%)
Once/week n ¼ 265
(27.4%)
>once/week n ¼ 366
(37.8%)
Mean SE Mean SE Mean SE
Global Composite 1 0.155 0.047 0.038c* 0.053 0.129c*** 0.045 0.262 <0.001
2 0.154 0.048 0.024c* 0.052 0.142c*** 0.046 0.302 <0.001
3 0.141 0.046 0.032c* 0.051 0.124c*** 0.044 0.353 <0.001
Visual-Spatial Memory and Organization 1 0.170 0.048 0.035c* 0.053 0.150c*** 0.046 0.239 <0.001
2 0.153 0.046 0.046c* 0.051 0.126c*** 0.045 0.345 <0.001
3 0.140 0.046 0.048c* 0.050 0.113c*** 0.044 0.368 <0.001
Verbal Memory 1 0.101 0.050 0.114c* 0.057 0.025 0.048 0.144 0.07
2 0.093 0.051 0.133c** 0.055 0.006 0.049 0.210 0.17
3 0.097 0.051 0.140c** 0.055 0.004 0.049 0.229 0.16
Working Memory 1 0.082 0.053 0.029 0.060 0.121 0.051 0.049 0.048
2 0.059 0.054 0.053 0.059 0.042 0.052 0.133 0.18
3 0.059 0.054 0.063 0.058 0.034 0.051 0.151 0.22
Scanning Tracking 1 0.110 0.045 0.029 0.050 0.121c** 0.043 0.331 <0.001
2 0.109 0.044 0.020 0.048 0.104c** 0.042 0.427 0.001
3 0.099 0.044 0.019 0.047 0.093c** 0.042 0.440 0.002
Similarities 1 0.143 0.053 0 0.060 0.144c*** 0.051 0.040 <0.001
2 0.087 0.050 0.041 0.055 0.086c* 0.048 0.222 0.015
3 0.076 0.050 0.047 0.054 0.072 0.048 0.256 0.037
Mini-Mental State Examination 1 0.090 0.053 0.024 0.060 0.079 0.051 0.042 0.023
2 0.066 0.052 0.059 0.057 0.076 0.050 0.156 0.053
3 0.069 0.052 0.061 0.056 0.077 0.050 0.174 0.048
Multivariate tests: covariate set 1: F (Wilks' lambda) ¼ 2.93, p < 0.001; covariate set 2: F ¼ 2.43, p ¼ 0.004; covariate set 3: F ¼ 2.21, p ¼ 0.009.
a Covariate set 1e adjustment for age and sex; Covariate set 2e adjustment for age, sex, education, total cholesterol, glucose, LDL-cholesterol, hypertension, and total serves
from all foods; Covariate set 3 e adjustment for variables in set 2 þ dietary intake of alcohol, meats, vegetables, and dairy foods.
b Adjusted R2 for multiple comparisons (Bonferroni).
c signiﬁcantly different from <once/week group, *p < 0.05, **p < 0.01, ***p < 0.001.
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psychomotor speed. However, the levels of caffeine and theobro-
mine administered in this study were higher than what is present
in chocolate products.
A number of recent reviews have explored the central actions of
cocoa ﬂavanols in relation to cognition (Sokolov et al., 2013) and
mood (Smith, 2013). Excellent reviews by (Sokolov et al. 2013) and
Williams and Spencer (2012) discuss how the actions of cocoa
ﬂavanols and ﬂavonoids, respectively, impact upon neurocognition
and behaviour. To summarize, ﬂavanols have multiple effects on
brain function, but their neuropsychological actions are likely to
occur in two ways: 1) via direct interactions with cellular and
molecular signalling cascades in brain regions involved with
learning and memory, and 2) via increasing central and peripheral
blood ﬂow and promoting angiogenesis (Sokolov et al., 2013;
Williams & Spencer, 2012).
Cardiovascular health is closely linked to cognitive health
(Waldstein and Elias, 2014). Further, the relation between dietary
habits and the human brain is complex and involves bi-directional
communication. Intellectual status early in life may certainly effect
good or poor food choices (Crichton et al., 2014). However, wewere
able to asses for any relation between cognitive performance
measured at waves 1e4 of the MSLS, with chocolate intake at wave
6, and found no prospective associations. Performance on theWAIS,
which combines both verbal and performance abilities, did not
predict chocolate intake controlling for age, sex, and education.
Income may be another factor that potentially inﬂuences the
relation between chocolate consumption and cognitive function. It
may be speculated that higher income individuals may purchase
and consume more chocolate, and in particular dark chocolate,
which has a higher ﬂavanol content. However, sensitivity analyses
with income added to the basic model, did not change the ﬁndings.
We also note that those who consumed chocolate more frequently
drank signiﬁcantly less alcohol. Another plausible explanation may
be that alcohol actually has a deleterious effect on cognitive func-
tion, explaining the results observed. However, additional analyses
revealed no association between alcohol intake and the Global
Composite, Visual-Spatial Memory and Organization, Scanning and
Tracking, or the Similarities test (all p > 0.2, all covariate set 3).
Alcohol intake was, in fact, signiﬁcantly, positively associated with
Verbal Memory, Working Memory and the MMSE (unstandardized
B ¼ 0.001, p < 0.05 for all, covariate set 3) (data not shown).
7. Limitations
Some limitations of the present study should be acknowledged.
Chocolate intake was self-reported, and therefore subject to
inherent reporting error. The dietary questionnaire used did not
require the respondent to differentiate between dark, milk or white
chocolate. Most clinical trials have used dark chocolate as the
source of cocoa ﬂavanols. In 2012, the distribution share of choc-
olate in the United States by favourite chocolate type was 57% milk
chocolate, 35% dark chocolate, and 8% white chocolate (Statista,
2015). We can therefore make the assumption that the majority
of chocolate consumed in this sample was dark or milk, both con-
taining cocoa ﬂavanols to varying degrees. With the exception of
the secondary analysis, the study was cross-sectional as longitu-
dinal data following wave 6 were not available. This precludes any
conclusions regarding a causal relationship between chocolate
intake and cognition from being drawn. Future longitudinal studies
in this area will be of value.
8. Strengths
Our study demonstrated positive associations between habitual
chocolate consumption and cognitive performance. We were able
to statistically control for a number of cardiovascular, lifestyle and
dietary variables that may impact upon a chocolateecognition
relationship. Despite the dietary intervention trials which have
typically examined the effects from either a single dose or daily
doses over periods up to several months, there have not been any
large cross-sectional studies identiﬁed that have speciﬁcally
examined chocolate intake in relation to cognitive performance.
Further, we were able, with a prospective design, to examine the
relation between early cognitive functioning (at waves 1 to 4) and
chocolate consumption (at wave 6), and found no association.
9. Conclusion
It is evident that nutrients in foods exert differential effects on
the brain. As has been repeatedly demonstrated, isolating these
nutrients and foods enables the formation of dietary interventions
to optimise neuropsychological health. Adopting dietary patterns
to delay or slow the onset of cognitive decline is an appropriate
avenue, given the limited treatments available for dementia. The
present ﬁndings support recent clinical trials suggesting that reg-
ular intake of cocoa ﬂavanols may have a beneﬁcial effect on
cognitive function, and possibly protect against normal age-related
cognitive decline. Longer-term clinical trials will shed further
insight into this association between chocolate, rich in cocoa ﬂa-
vanols, and neuropsychological health, and themechanisms linking
them. It will be important in future studies to investigate optimal
quantities and duration of consumption to produce short or longer-
tem effects while taking into account overall dietary patterns,
where foods high in ﬂavonoids are consumed in combination.
Enhancing chocolate and cocoa consumption whilst ensuring
appropriate caloric intake will be an important consideration to
optimise the beneﬁts obtained from these foods.
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